Arsenic trioxide, a drug created to treat leukemia patients, has come under scrutiny by the FDA after two separate clinical trials resulted in drug-related deaths. Cell Therapeutics of Seattle, the maker of the arsenic trioxide drug Trisenox, is evaluating the results of these two trials.
The medical journal Bloo